Ian McCreary—who grew up in Oregon—remembers being in the 6th grade and getting up around 4 a.m. to go fishing for steelhead ...

Your nervous system is a key force behind so many important bodily functions. But when your peripheral nerves-those found ...

NORTH CHICAGO, IL, USA I 18, 2024 I AbbVie (NYSE: ABBV) today announced the European Commission (EC) granted marketing authorization for ELAHERE® ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

Additionally, 75% of the patients undergoing treatment with gemcitabine plus albumin-bound paclitaxel did not develop CIPN by day 84. Peripheral neuropathy is a common adverse effect of neurotoxic ...

Preclinical and clinical data demonstrate that BXQ-350 is a potent allosteric activator of wild type and mutated glucocerebrosidase (GCase). A key mutation in the GBA gene, which encodes GCase, ...

For example, a combined anemia (such as the combination of chemotherapy-related bone marrow suppression plus vitamin B12 deficiency) may not be obvious from a complete blood count alone. Further ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Gorgas, President and CEO of Artelo Biosciences. “Starting with ART26.12, our promising Fatty Acid Binding Protein 5 (FABP5) inhibitor drug candidate, we received FDA clearance to begin trials in ...

Topical treatments may help ease chemotherapy-induced peripheral neuropathy, but more research is needed. Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients ...

chemotherapy can contribute to the development of other cancers. Radiation, blood transfusions, and bone marrow or peripheral blood stem cell transplants can also involve side effects. Talk with ...